Catheter-Disinfecting System and Methods Thereof

    公开(公告)号:US20240335636A1

    公开(公告)日:2024-10-10

    申请号:US18132261

    申请日:2023-04-07

    CPC classification number: A61M25/00 A61M2025/0019

    Abstract: A catheter-disinfecting system can include, in some embodiments, an introducer sheath and a germicidal irradiation means for irradiating a catheter tube of a catheter with germicidal radiation. The introducer sheath can include a sheath body configured to be percutaneously inserted into an insertion site of a patient. The germicidal irradiation means can be configured for irradiating the catheter tube as the catheter tube is inserted into a lumen of the introducer sheath, thereby disinfecting the catheter tube immediately before insertion into the insertion site. A method of disinfecting a catheter such as the foregoing catheter can include inserting the catheter tube into the introducer sheath while the introducer sheath, itself, is percutaneously inserted into the insertion site of the patient; and irradiating the catheter tube with the germicidal radiation while inserting the catheter tube into the introducer sheath.

    NITRIC OXIDE-RELEASING DISINFECTION INSERT
    4.
    发明公开

    公开(公告)号:US20240245819A1

    公开(公告)日:2024-07-25

    申请号:US18561613

    申请日:2022-05-19

    Abstract: Disclosed herein are disinfection inserts comprising a fiber optic and a polymer surrounding at least a portion of the fiber optic (and methods of making and using the same). The polymer comprises a NO donor molecule that releases NO upon illumination of the polymer by the fiber optic. The disinfection inserts can be inserted into tubing, catheters, and/or extracorporeal devices and illuminated to release NO from the polymer. The released NO inactivates pathogens on or within the tubing, catheter, and/or extracorporeal device. The disinfection insert can be configured for removable attachment to the tubing, catheter, and/or extracorporeal device, such that it can be periodically replaced. Furthermore, the disinfection insert can be placed in optical communication with a controllable light source. The controllable light source can be coupled to a light source controller. The intensity and wavelength of the light can be varied to change the flux of NO.

    Dialysis Sheath For Use In Accessing A Dialysis Arteriovenous Graft Or Fistula And Methods Of Use

    公开(公告)号:US20240207500A1

    公开(公告)日:2024-06-27

    申请号:US18598483

    申请日:2024-03-07

    Inventor: Evan T. Neville

    CPC classification number: A61M1/3661 A61M25/1002 A61M2025/0019 A61M2025/109

    Abstract: A dialysis sheath is used with a catheter that cleans clots from a synthetic blood vessel or fistula. The dialysis sheath comprises a main hollow body and a stop mechanism. The main body has a lower portion for insertion into the synthetic blood vessel or fistula. The stop mechanism is movable between (i) a first position in which the stop mechanism is adjacent to or within a surface of the main hollow body and (ii) a second position in which the stop mechanism radially protrudes from the main hollow body. The stop mechanism is configured to engage an inner surface of the synthetic blood vessel or fistula to maintain the lower portion of the dialysis sheath within the synthetic blood vessel or fistula when the dialysis sheath is moved to a different position. The stop mechanism can be fluid-actuated and include a balloon-like structure.

    Method for decolonizing mammalian skin

    公开(公告)号:US11925768B2

    公开(公告)日:2024-03-12

    申请号:US16054017

    申请日:2018-08-03

    Inventor: Stephen T. Woody

    Abstract: A method for insertion, maintenance, and removal of urethral catheters in mammals including humans includes steps for preventing or reducing the incidence of catheter associated urinary tract infections. In addition to sterile procedures currently practiced or as may be practiced in the future in connection with catheter use, the method includes the steps of applying an antiseptic, zwitterionic, and acidic skincare solution capable of preserving the stratum corneum to the perineum, meatus, and contiguous mucosa surrounding the insertion site before insertion, after insertion, periodically during the period of indwelling, in connection with any incidence of incontinence, and, optionally, before and after removal of the catheter. Application of the solution optionally is continued after catheter removal on a periodic basis until the threat of an infection associated with catheter use has passed, typically at least about five (5) to seven (7) days and up to thirty (30) days. The solution pH is desirably from about 4.4 to 5.5.

Patent Agency Ranking